. 2015 Aug 28;16(1):235–245. doi: 10.1111/ajt.13426

Table 1.

Demographic and clinical features, overall and by analysis groups

	All patients	NGT	HG‐T1DR	HG‐PCR	HG‐UND	p value
N	223	176	17	10	20	n/a
% of total (223)	n/a	78.9	7.6	4.5	9	n/a
% of HG (47)	n/a	n/a	36.2	21.3	42.6	n/a
Sex (F‐M)	106–117	89–87	8–9	1–9	8–12	p=0.1494¹
White not Hispanic, n (%)	117 (52.5)	96 (54.5)	9 (52.9)	5 (50.0)	7 (35.0)	p=0.3028²
White Hispanic, n (%)	83 (37.2)	63 (35.8)	8 (47.1)	3 (30.0)	9 (45.0)	n/a
African‐American, n (%)	22 (9.9)	16 (9.1)	0	2 (20.0)	4 (20.0)	n/a
Other, n (%)	1 (0.4)	1 (0.6)	0	0	0	n/a
Age at T1D onset mean ± SD (years)	14 ± 8.6	14.3 ± 8.4	13.9 ± 10.7	9.1 ± 5.3	14.7 ± 8.8	p=0.3159^a
Range (years)	0–39	0–38	2–39	1–17	4–32	n/a
Patients with no available data	2	1	0	0	1	n/a
T1D duration at transplantation mean ± SD (years)	26.6 ± 8.6	27.5 ± 8.4	20.9 ± 10.0	27.6 ± 5.0	23.1 ± 7.8	p = 0.0161
Range (years)	2–50	3–50	2–39	22–35	8–36	n/a
Patients with no available data	2	1	0	0	1	n/a
Age at transplant mean ± SD (years)	40.7 ± 8.0	41.8 ± 8.1	34.8 ± 6.6	36.6 ± 4.4	38.2 ± 6.3	p = 0.0006
Range (years)	23–60	23–60	23–47	30–44	29–50	n/a
Length of follow‐up mean ± SD (years)	6.2 ± 4.1	6.2 ± 4.2	6.8 ± 3.8	4.5 ± 2.9	6.2 ± 4.4	p = 0.5029*
Range (years)	1.0–22.6	1.0–22.6	2.2–17.2	2.1–10.3	1.1–15.6	n/a
Last HbA1c on follow‐up mean ± SD	5.7 ± 0.7	5.5 ± 0.4	6.9 ± 0.9	6.9 ± 1.1	7.1 ± 0.8	p < 0.0001
Patients with no available data	54	32	12	7	3	n/a

HG‐PCR, hyperglycemia with pancreas chronic rejection; HG‐T1DR, hyperglycemia with type 1 diabetes recurrence; NGT, normal glucose tolerance.

Overall p values of the chi‐square test are shown for independence between sex¹ or ethnicity² (excluding “other”) and group classification (NGT, HG‐T1DR, HG‐PCR, HG‐UND).

One‐ way analysis of variance (Global Kruskal–Wallis test).